Financial Ratios

SUNIL HEALTHCARE LTD.

NSE : NABSE : 537253ISIN CODE : INE671C01016Industry : ChemicalsHouse : Private
BSE66.203.15 (+5 %)
PREV CLOSE ( ) 63.05
OPEN PRICE ( ) 64.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4494
TODAY'S LOW / HIGH ( )64.90 66.20
52 WK LOW / HIGH ( ) 45.6580
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)6.806.610.27-4.060.17
   CEPS(Rs)13.6412.766.231.915.77
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)57.3250.5644.0143.7247.92
   Tax Rate(%)28.5129.2021.2128.3928.97
Margin Ratios
   Core EBITDA Margin(%)17.0815.316.84-11.0014.72
   EBIT Margin(%)12.4511.226.291.628.57
   Pre Tax Margin(%)8.738.220.39-8.300.31
   PAT Margin (%)6.245.820.31-5.940.22
   Cash Profit Margin (%)12.5111.247.112.807.28
Performance Ratios
   ROA(%)5.865.750.21-3.040.13
   ROE(%)12.6113.980.61-8.870.36
   ROCE(%)15.4714.486.011.156.52
   Asset Turnover(x)0.940.990.700.510.58
   Sales/Fixed Asset(x)1.061.170.960.800.99
   Working Capital/Sales(x)13.39-392.89-115.73-16.85-12.80
Efficiency Ratios
   Fixed Capital/Sales(x)0.940.861.041.241.01
   Receivable days93.8578.07114.54182.18200.72
   Inventory Days36.5433.2468.4297.4855.63
   Payable days88.5281.53154.70292.29245.96
Valuation Parameters
   PER(x)8.3810.7785.100.00197.52
   PCE(x)4.185.583.677.775.94
   Price/Book(x)0.991.410.520.340.71
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.810.890.720.851.08
   EV/Core EBITDA(x)4.315.375.508.226.90
   EV/EBIT(x)6.497.9611.4552.5412.58
   EV/CE(x)0.720.930.520.440.63
   M Cap / Sales0.520.630.260.220.43
Growth Ratio
   Net Sales Growth(%)-3.9029.4728.17-13.68-8.94
   Core EBITDA Growth(%)8.1164.5262.06-42.83-25.49
   EBIT Growth(%)6.63130.83397.79-83.68-43.22
   PAT Growth(%)2.952361.61106.61-2443.25-96.66
   EPS Growth(%)2.952361.23106.61-2443.02-96.66
Financial Stability Ratios
   Total Debt/Equity(x)0.600.661.091.101.12
   Current Ratio(x)1.190.990.990.940.91
   Quick Ratio(x)0.910.730.770.600.71
   Interest Cover(x)3.343.741.070.161.04
   Total Debt/Mcap(x)0.600.472.103.241.57

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.